Cambridge Investment Research Advisors, Inc. Precigen, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Precigen, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 147,835 shares of PGEN stock, worth $110,876. This represents 0.0% of its overall portfolio holdings.

Number of Shares

147,835

Previous 76,800 92.49%

Holding current value

$110,876

Previous $121,000 15.7%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$0.91 - $1.88 $64,641 - $133,545	71,035 Added 92.49%	147,835 $140,000
Q2 2024 Jul 26, 2024	SELL	$1.27 - $1.75 $1,757 - $2,422	-1,384 Reduced 1.77%	76,800 $121,000
Q1 2024 Apr 24, 2024	BUY	$1.21 - $1.75 $10,648 - $15,400	8,800 Added 12.68%	78,184 $113,000
Q4 2023 Feb 09, 2024	SELL	$0.89 - $1.41 $10,813 - $17,131	-12,150 Reduced 14.9%	69,384 $93,000
Q3 2023 Oct 24, 2023	BUY	$1.08 - $1.85 $6,480 - $11,100	6,000 Added 7.94%	81,534 $116,000
Q2 2023 Jul 13, 2023	BUY	$0.96 - $1.4 $8,280 - $12,075	8,625 Added 12.89%	75,534 $87,000
Q1 2023 May 11, 2023	BUY	$0.88 - $2.19 $16,060 - $39,967	18,250 Added 37.51%	66,909 $71,000
Q4 2022 Feb 08, 2023	SELL	$1.27 - $2.26 $3,232 - $5,751	-2,545 Reduced 4.97%	48,659 $74,000
Q3 2022 Oct 17, 2022	SELL	$1.41 - $2.79 $10,835 - $21,441	-7,685 Reduced 13.05%	51,204 $108,000
Q2 2022 Jul 13, 2022	SELL	$1.15 - $2.53 $5,866 - $12,905	-5,101 Reduced 7.97%	58,889 $78,000
Q1 2022 May 12, 2022	BUY	$1.91 - $3.98 $6,637 - $13,830	3,475 Added 5.74%	63,990 $135,000
Q4 2021 Feb 03, 2022	SELL	$3.53 - $5.5 $35,430 - $55,203	-10,037 Reduced 14.23%	60,515 $224,000
Q3 2021 Nov 02, 2021	BUY	$4.99 - $6.55 $14,221 - $18,667	2,850 Added 4.21%	70,552 $352,000
Q2 2021 Aug 10, 2021	BUY	$6.24 - $8.22 $74,249 - $97,809	11,899 Added 21.32%	67,702 $441,000
Q1 2021 May 07, 2021	BUY	$6.74 - $10.95 $34,717 - $56,403	5,151 Added 10.17%	55,803 $384,000
Q4 2020 Feb 04, 2021	SELL	$3.75 - $10.56 $89,737 - $252,700	-23,930 Reduced 32.09%	50,652 $516,000
Q3 2020 Oct 29, 2020	BUY	$3.5 - $6.2 $14,787 - $26,195	4,225 Added 6.01%	74,582 $261,000
Q2 2020 Jul 27, 2020	SELL	$2.16 - $5.46 $2,646 - $6,688	-1,225 Reduced 1.71%	70,357 $351,000
Q1 2020 May 08, 2020	BUY	$1.46 - $7.19 $104,509 - $514,674	71,582 New	71,582 $243,000

Others Institutions Holding PGEN

# of Institutions

143

Shares Held

159M

Call Options Held

232K

Put Options Held

69K

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $156M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account

Cambridge Investment Research Advisors, Inc. Precigen, Inc. Transaction History